[Latin Name] Epimedium sagittatnm Maxim

[Plant Source] Leaf

[Specification] Icariin 10% 20% 40% 50%

[Appearance] Light yellow fine powder

Plant Part Used: Leaf

[Particle size]80Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Pesticide residue] EC396-2005, USP 34, EP 8.0, FDA

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

[What is Epimedium?]

Epimedium extract is a popular aphrodisiac supplement and herbal sexual performance enhancer.It has a long history of traditional use in China for the alleviation of erectile dysfunction and for improving libido and fertility.

Also known as Horny Goat Weed, this supplement supposedly got its name after a farmer noticed that his flock of goats were particularly aroused after eating flowers of a specific type. These Epimedium flowers contain icariin, which is a natural compound that increases blood flow to sexual organs and promotes sex drive. Icariin has been found to increase Nitric Oxide synthesis as well as inhibiting the activity of the PDE-5 enzyme

[Icariin in Epimedium Extract]

Epimedium extracts powder contain an active phytochemical called icariin.Icariin has been observed to exhibit a number of useful traits, including renoprotective (liver protecting) hepatoprotective (kidney protecting), cardioprotective (heart protecting) and neuroprotective (brain protecting) effects.

It is also an antioxidant and can cause vasodilation. It exhibits antimicrobial characteristics and is thought to act as an aphrodisiac.

Icariin is classified as a flavonol glycoside, which is a type of flavonoid. Specifically, icariin is the 8-prenyl derivation of kaempferol 3,7-O-diglucoside, a prevalent and important flavonoid.

[Function]

1. Combat mental and physical fatigue;

2. Induce vasodilation and improve circulation;

3. Lower blood pressure in hypertensive patients;

4. Improve symptoms of erectile dysfunction (ED) through its action as a PDE5  inhibitor;

5. Improve the use of free testosterone in the blood;

6. Increase libido;

7. Alleviate symptoms of depression and stimulate improved cognitive function;

8. Protect against neurological degeneration.

Video abstract of original research paper “In vitro inhibition of hyaluronidase by sodium copper chlorophyllin complex and chlorophyllin analogs” published in the open access journal Clinical, Cosmetic and Investigational Dermatology by McCook et al.

Background: Inhibitors of hyaluronidase are potent agents that maintain hyaluronic acid homeostasis and may serve as anti-aging, anti-inflammatory, and anti-microbial agents. Sodium copper chlorophyllin complex is being used therapeutically as a component in anti-aging cosmeceuticals, and has been shown to have anti-hyaluronidase activity. In this study we evaluated various commercial lots of sodium copper chlorophyllin complex to identify the primary small molecule constituents, and to test various sodium copper chlorophyllin complexes and their small molecule analog compounds for hyaluronidase inhibitory activity in vitro. Ascorbate analogs were tested in combination with copper chlorophyllin complexes for potential additive or synergistic activity.
Materials and methods: For hyaluronidase activity assays, dilutions of test materials were evaluated for hydrolytic activity of hyaluronidase by precipitation of non-digested hyaluronate by measuring related turbidity at 595 nm. High-performance liquid chromatography and mass spectroscopy was used to analyze and identify the primary small molecule constituents in various old and new commercial lots of sodium copper chlorophyllin complex.
Results: The most active small molecule component of sodium copper chlorophyllin complex was disodium copper isochlorin e4, followed by oxidized disodium copper isochlorin e4. Sodium copper chlorophyllin complex and copper isochlorin e4 disodium salt had hyaluronidase inhibitory activity down to 10 μg/mL. The oxidized form of copper isochlorin e4 disodium salt had substantial hyaluronidase inhibitory activity at 100 μg/mL but not at 10 μg/mL. Ascorbate derivatives did not enhance the hyaluronidase inhibitory activity of sodium copper chlorophyllin. Copper isochlorin e4 analogs were always the dominant components of the small molecule content of the commercial lots tested; oxidized copper isochlorin e4 was found in increased concentrations in older compared to newer lots tested.
Conclusion: These results support the concept of using the hyaluronidase inhibitory activity of sodium copper chlorophyllin complex to increase the hyaluronic acid level of the dermal extracellular matrix for the improvement of the appearance of aging facial skin.

View the original paper here: https://www.dovepress.com/in-vitro-inhibition-of-hyaluronidase-by-sodium-copper-chlorophyllin-co-peer-reviewed-article-CCID